HECTOR ESCAJEDA: Open Payments
NPI 1184991564 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 28 payments from 7 companies in 2025. Trend: 2023 $598 · 2024 $1,656 · 2025 $857
Food & beverage: $784Education: $73
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $204 |
| Sumitomo Pharma America, Inc. | 7 | $184 |
| Astellas Pharma US Inc | 2 | $166 |
| Janssen Biotech, Inc. | 3 | $115 |
| COLOPLAST CORP | 2 | $90 |
| Ferring Pharmaceuticals Inc. | 4 | $81 |
| Endo USA, Inc. | 1 | $16 |
Products named: GEMTESA, AMS 800 Artificial Urinary Sphincter, Xtandi, AMS 700, ADSTILADRIN, Altis, RYBREVANT, ERLEADA.
Industry payments across TX — which companies pay providers there.
